Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Published:2016-12 Issue:10062 Volume:388 Page:2873-2884
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Gauthier Serge,Feldman Howard H,Schneider Lon S,Wilcock Gordon K,Frisoni Giovanni B,Hardlund Jiri H,Moebius Hans J,Bentham Peter,Kook Karin A,Wischik Damon J,Schelter Bjoern O,Davis Charles S,Staff Roger T,Bracoud Luc,Shamsi Kohkan,Storey John M D,Harrington Charles R,Wischik Claude M

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Defeating Alzheimer's disease and other dementias: a priority for European science and society;Winblad;Lancet Neurol,2016

2. World Alzheimer report 2015—the global impact of dementia: an analysis of prevalence, incidence, cost and trends;Prince,2015

3. Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?;Mullane;Biochem Pharmacol,2013

4. Subunit structure of paired helical filaments in Alzheimer's disease;Wischik;J Cell Biol,1985

5. Structural characterization of the core of the paired helical filament of Alzheimer disease;Wischik;Proc Natl Acad Sci USA,1988

Cited by 322 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 8-weeks aerobic exercise ameliorates cognitive deficit and mitigates ferroptosis triggered by iron overload in the prefrontal cortex of APPSwe/PSEN1dE9 mice through Xc−/GPx4 pathway;Frontiers in Neuroscience;2024-09-09

2. Updates in Alzheimer's disease: from basic research to diagnosis and therapies;Translational Neurodegeneration;2024-09-04

3. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies;Signal Transduction and Targeted Therapy;2024-08-23

4. Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-08

5. Recent Advances in the Treatment and Management of Alzheimer’sDisease: A Precision Medicine Perspective;Current Topics in Medicinal Chemistry;2024-07